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Abstract
Background: Objectively measuring daily physical activity (PA) using an accelerometer is a relatively expensive and time-
consuming undertaking. In routine clinical practice it would be useful to estimate PA in patients with chronic obstructive
pulmonary disease (COPD) with more simple methods.
Objectives: To evaluate whether PA can be estimated by simple tests commonly used in clinical practice in patients with
COPD.
Methods: The average number of steps per day was measured for 7 days with a SenseWear ProTM accelerometer and used
as gold standard for PA. A physical activity level (PAL) of ,1.4 was considered very inactive. Univariate and multivariate
analyses were used to examine the relationship between the 6-minute walking distance (6MWD), the number of stands in the
Sit-to-Stand Test (STST), hand-grip strength and the total energy expenditure as assessed by the Zutphen Physical Activity
Questionnaire (TEEZPAQ). ROC curve analysis was used to identify patients with an extremely inactive lifestyle (PAL,1.4).
Results: In 70 patients with COPD (21 females) with a mean [SD] FEV1 of 43.0 [22.0] %predicted, PA was found to be
significantly and independently associated with the 6MWD (r = 0.69, 95% CI 0.54 to 0.80, p,0.001), STST (r = 0.51, 95% CI
0.31 to 0.66, p = 0.001) and TEEZPAQ (r = 0.50, 95% CI 0.30 to 0.66, p,0.001) but not with hand-grip strength. However, ROC
curve analysis demonstrated that these tests cannot be used to reliably identify patients with an extremely inactive lifestyle.
Conclusions: In patients with COPD simple tests such as the 6-Minute Walk Test, the Sit-to-Stand Test and the Zutphen
Physical Activity Questionnaire cannot be used to reliably predict physical inactivity.
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Introduction
Physical inactivity in daily life is a prominent feature in patients
with chronic obstructive pulmonary disease (COPD) [1–4].
Reduced physical fitness may lead to a shift in patients’ lifestyle
with low daily physical activity levels (PA) inducing a vicious circle
of decreased exercise tolerance, which in turn further reduces
activity levels and increases social isolation and depression [5].
The Global Initiative for Chronic Obstructive Lung Disease
(GOLD) states that increased participation in physical and social
activities of daily living should be among the pertinent clinical
issues in the management of patients with COPD [6]. Due to the impact of
impaired PA on the health status in patients with COPD,
accurately estimating the amount and intensity of physical activity
in daily life is considered very important [7].
Physical performance in patients with COPD has been assessed
mostly by direct observation, by subjective methods such as self-
reported questionnaires and diaries [8] and by objective methods
such as accelerometers, pedometers [9] and physical fitness tests
such as the 6-Minute Walk Test (6MWT), the Sit-to-Stand Test
(STST) [10] and the Hand-grip strength Test [11]. Objectively
measuring PA using accelerometry seems to be the most accurate field-
based estimate of PA [12], however, it is a relatively expensive and
time-consuming undertaking. In routine clinical practice it would be
useful to estimate PA with less expensive, less time-consuming and
more practical methods. Therefore, the aim of the present study
was to investigate if the 6MWT, STST, Hand-grip strength Test
and Zutphen Physical Activity Questionnaire (ZPAQ) can
accurately predict daily PA in patients with COPD.
Study Subjects
Patients with COPD referred to the Pulmonary Division,
University Hospital of Zurich, Switzerland between January 2010
and August 2011 were considered for participation in the study.
The inclusion criteria for patients were: male/female subjects aged
40–75 yrs and confirmed COPD according to GOLD-guidelines.
The exclusion criteria were: acute or recent (within last 6 weeks)
exacerbation of COPD according to GOLD-guidelines, patients
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on long-term oral corticosteroids or morphine medication and
mental or physical disability precluding informed consent or
compliance with the protocol. The study was approved by the
Research Ethics Committee of the University Hospital of Zurich,
Switzerland (EK-1734) and written informed consent was
obtained from all patients.
Methods
Pulmonary Function
Spirometry, whole body plethysmography and diffusing capac-
ity measurements were performed according to the American
Thoracic Society (ATS) and the European Respiratory Society
(ERS) guidelines with a commercially available system [12,13].
Daily Physical Activity, Accelerometry
A multisensor accelerometer (SenseWear ProTM armband;
BodyMedia, Inc., Pittsburgh, PA, USA) which is worn on the
upper right arm was used. The device estimates energy
expenditure (EE) using measurements from a biaxial accelerom-
eter and sensors that quantify galvanic skin response, heat flux and
skin temperature. The biaxial accelerometer records the number
of steps and the duration of physical activity (PAD) [14]. The
physical activity level (PAL) was calculated by dividing the total
daily energy expenditure by energy expenditure during sleep [15].
A PAL $1.70 defines a moderate to extremely active person,
1.40–1.69 defines a sedentary person, and ,1.40 defines an
extremely inactive person [15–17]. The patients were instructed to
wear the accelerometer continuously during 7 consecutive days,
except when bathing or showering.
6-Minute Walking Test
Patients performed the 6MWT following pulmonary function
testing. 6MWT distance was measured according to the guidelines
of the American Thoracic Society (ATS) [18]. The 6MWT was
performed on a 30-meter indoor track by an experienced
investigator using standardized encouragement strategy. None of
the patients used a walking aid in daily life or during the test.
Sit-to-Stand Test
A standard chair (height 46 cm) with no arm supports was used.
The patients were instructed to stand up from and sit down on the
chair with no support from the hands, repeating the procedure as
many times as possible for a duration of one minute at a patient-
defined pace [10].
Hand-grip Strength Test
Skeletal muscle strength of the hand was estimated based on
handgrip strength of the dominant hand measured with a
dynamometer as described elsewhere (Hand-Dynamometer Brem-
shey; Accell Fitness, Almere, Netherlands) [19].
Zutphen Physical Activity Questionnaire
The ZPAQ has been used to characterize PA in daily life in
patients with COPD [20]. The ZPAQ [21] is a self-reported
physical activity questionnaire and addresses the frequency and
duration of the patients` activities of the previous week; the average
amount of time spent weekly on ‘‘homely activities’’, ‘‘gardening’’,
‘‘hobbies’’ and the average amount of time spent monthly on
‘‘jobs’’ and ‘‘sports’’. According to the frequency, intensity and
duration of these activities, a summary Metabolic Equivalent
(MET) score expressed in kcal/kg/day is calculated based on an
intensity code for each activity, as described by Durrin and
Passmore [22] and the Minnesota leisure-time physical activity
questionnaire as described by Jacobs [23] and Folsom [24].
Data Analysis
A statistical software package was used for all calculations
(SPSS for Windows, version 11.0, SPSS Inc., Chicago, IL,
USA). Descriptive data for continuous variables are expressed as
mean and standard deviation. Univariate (Pearson’s correlation) and
multivariate analyses were performed to evaluate the association
between PA (the average number of steps per day) and the
6MWT, STST, Hand-grip Test as well as the ZPAQ. The
multivariate analysis included the average number of steps per
day derived from accelerometry as the dependent and either
6MWT, STST, Hand-grip strength Test or ZPAQ as well as
partial pressure of oxygen (PaO2), forced expiratory volume in
one second (FEV1), age and body mass index (BMI) as
independent variables. ROC curve analysis was used to
compare the predictive ability of the 6MWT, STST, Hand-
grip strength Test and the ZPAQ and to determine the most
useful threshold to identify subjects with extremely low physical
activity (PAL,1.4). A p-value of ,0.05 was considered to
indicate statistical significance.
Results
Study Profile and Patients’ Characteristics
Figure 1 shows the study profile. Seventy patients with COPD
agreed to take part and were included in the study. Anthropome-
trical characteristics and pulmonary function data of the patients
are presented in table 1. COPD was mild (GOLD I) in 23.9%,
moderate (GOLD II) in 8.5%, severe (GOLD III) in 31.0%, and
very severe (GOLD IV) in 36.6% of the patients.
Physical Activity
Data describing physical activity are summarized in table 2.
The mean PAL of the patients was 1.47 (0.23); 42.2% of the
patients had an extremely inactive lifestyle (PAL,1.4), 40.2% of
the patients had a sedentary lifestyle (PAL 1.40–1.69) and 17.6%
of the patients were classified as moderate to vigorously active
(PAL$1.70). Mean total energy expenditure (TEEACC) estimated
by accelerometry was higher than total energy expenditure
(TEEZPAQ) assessed by the self-reported physical activity ques-
tionnaire: 2200 [478] and 1292 [1093] kcal/day, respectively
(mean difference 922 [95] kcal/day, 95% CI 703 to 1141 kcal/
day, p,0.001).
Relationship between Accelerometry and Physical
Performance Tests
There was a statistically significant positive correlation
between the average number of steps per day measured by
accelerometry and the 6-minute walking distance (6MWD), the
number of stands during the STST, the metabolic equivalent as
measured by accelerometry (MET), the total energy expenditure
estimated by accelerometry (TEEACC), the time spent per day
on activities demanding more than 3 metabolic equivalents
(TSA) and the total energy expenditure as assessed by the self-
reported physical activity questionnaire (TEEZPAQ) (table 3,
figure 2).
The results of the multivariate analyses are shown in table 4.
The average number of steps per day was found to be
independently associated with the 6MWD, STST and TEEZPAQ. By
using 6MWD in the multivariate analysis 49.9% of the variance
in daily PA could be explained by the model (table 4). STST and
Physical Activity in COPD
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TEEZPAQ explained 51.7% and 47.9% of the variance in PA,
respectively (table 4).
Prediction of Extreme Inactivity
ROC curve analysis revealed that only the 6MWT had modest
predictive capacity (area under the curve 0.68). Corresponding
analyses for the STST and the ZPAQ showed an area under the
curve of 0.31 and 0.43 respectively. Therefore, only the 6MWD
was used for further analysis and 425 m appeared as the most
useful cut-off point to predict a very inactive lifestyle with a
positive and negative predictive value of 0.46 and 0.65 respectively
(likelihood ratio of 1.20).
Figure 1. Study profile.
doi:10.1371/journal.pone.0048081.g001
Table 1. Anthropometrics and Pulmonary Function.
Variable
Anthropometrics
Subjects (n) 70
Female/male 21/49
Age (years) 62.4 (7.4)
BMI (kg/m2) 25.0 (7.7)
Pulmonary function
FEV1 (l) 1.2 (0.7)
FEV1 (% predicted) 43.0 (22.0)
FEV1/FVC (ratio) 43.6 (15.0)
DLCO (% predicted) 48.2 (23.6)
TLC (% predicted) 116.8 (20.9)
RV/TLC (ratio) 0.57 (0.14)
PaO2 (kPa) 9.2 (1.9)
PaCO2 (kPa) 5.2 (0.8)
Values are presented as mean (SD). BMI: body mass index; FEV1: forced
expiratory volume in one second; FEV1/FVC ratio: forced expiratory volume in
1 sec (FEV1) expressed as percent of FVC; DLCO: diffusion capacity for carbon
monoxide; TLC: total lung capacity; RV/TLC: residual volume/total lung capacity
ratio; PaO2: partial pressure of oxygen; PaCO2: partial pressure of carbon
dioxide.
doi:10.1371/journal.pone.0048081.t001
Table 2. Physical Performance.
Variable
Physical fitness
6MWD (m) 384.3 (136.4)
6MWD (% predicted) 63.4 (21.2)
Sit-to-Stand Test (n) 20 (6)
Hand-grip Test (kg) 37.3 (10.2)
Daily physical activity by accelerometry
PAL (ratio) 1.47 (0.23)
MET (kcal/h/kg) 1.2 (0.22)
TEEACC (kcal/day) 2200 (478)
TSA.3METs (min/day) 55.2 (62.23)
Steps/day (n) 5272 (3319)
Questionnaire-based daily physical activity
Stairs per week (n) 7.6 (9.4)
Total (MET/week) 118.1 (96.1)
TEEZPAQ (kcal/day) 1292 (1093)
Values are presented as mean (SD). PAL: physical activity level; MET: metabolic
equivalent; TEEACC: total energy expenditure per day as assessed by
accelerometry; TSA.3METs: time spend per day in activities demanding more
than 3 metabolic equivalents; steps/day: number of steps per day; TEEZPAQ: total
energy expenditure per day as assessed by the Zutphen Physical Activity
Questionnaire.
doi:10.1371/journal.pone.0048081.t002
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Relationship between Disease Severity and Physical
Performance
Statistically significant positive correlations were found between FEV1
(%predicted) and 6MWD (r = 0.60, 95% CI 0.43 to 0.73, p,0.001),
the average number of steps per day (r = 0.50, 95% CI 0.30 to
0.66, p,0.001), STST (n) (r = 0.37, 95% CI 0.15 to 0.56,
p = 0.014), TEEACC (r = 0.32, 95% CI 0.09 to 0.52, p= 0.011) and
TEEZPAQ (r = 0.31, 95% CI 0.28 to 0.44, p= 0.012) (figure 3) but
not with hand-grip strength (r = 0.059, 95% CI 20.18 to 0.29,
p = 0.696).
Discussion
Methods capable of accurately estimating PA levels and thus
quantifying the level of disability are becoming an increasingly
important clinical issue in the management of patients with COPD.
Accelerometry is the most accepted method used to measure PA
[14]. We investigated the usefulness of less expensive, less time-
consuming and more practical methods and found that the 6-
minute walking distance (6MWD), the number of stands in the
STST and the total energy expenditure as assessed by the ZPAQ
were independently associated with the average number of steps
per day. Despite this, we found that these tests cannot be used to
Figure 2. Scatterplots showing the relationship between PA (the average number of steps per day, n) and A: the 6-Minute Walking
Distance, 6MWD (r =0.69, 95% CI 0.54 to 0.80, p,0.001), B: hand-grip strength (r =0.21, 95% CI 20.03 to 0.42, p=0.190), C: Sit-to-
Stand Test, STST (r =0.51, 95% CI 0.31 to 0.66, p=0.001) and D: the total energy expenditure as assessed by the Zutphen Physical
Activity Questionnaire, TEEZPAQ (r =0.50, 95% CI 0.30 to 0.66, p,0.001).
doi:10.1371/journal.pone.0048081.g002
Physical Activity in COPD
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accurately predict an extremely inactive lifestyle in patients with
COPD.
In clinical practice, the 6MWT is widely used to assess physical
fitness in patients with COPD [25]. The 6MWT is easy to
perform, has been standardized [18], and is well tolerated by
patients with COPD. Furthermore, the 6MWD has been
suggested to be an independent predictor of mortality in patients
with COPD [26]. Compared to the age, sex, height and weight
matched normal values of Troosters and colleagues [29] the mean
6MWD of our patients was 63.4% predicted. Several authors have
proposed that 6MWD and PA as assessed by accelerometry are
associated in patients with COPD [9,27–31]. The findings of the
current study corroborate these earlier results, however, ROC curve
analysis revealed that the 6MWT cannot be used to reliably predict a
very inactive lifestyle.
The STST is an accepted measure of functional status in both
elderly people [32] and in patients with COPD [33,34]. The
number of stands during the STST correlates with the BODE
Index [26] and is considered a predictor of disease severity [34].
The test is almost self- explanatory and consumes less time, is
better tolerated by patients and produces less hemodynamical
stress compared to the 6MWT [34]. In the current study, we
found that the number of stands during the STST was correlated
with FEV1 and independently associated with PA. However, ROC
curve analysis revealed that the STST cannot be used to predict a very
inactive lifestyle.
Pitta and colleagues stated [9] that PA could be better predicted
by a ‘‘global’’ or ‘‘integrative’’ test (e.g. 6MWT) rather than by
tests focused on single components of physical functioning, such as
lung function or muscle strength. In accordance, we found that
peripheral muscle strength of the hand as measured by the Hand-
grip strength test was not associated with daily PA and thus may
not be used to estimate daily physical activity.
The ZPAQ can be self-completed in 15 minutes and showed a
good internal reliability, test-retest reliability and validity in a
general population of elderly men [24]. In the current study, we
found that the daily energy expenditure as assessed by the ZPAQ
(TEEZPAQ) was independently associated with PA. This is
interesting, as the use of self-reported activity questionnaires has
been challenged as a poor measure of actual PA in daily life [35]
due to limited validity and reliability [36] as well as due to poor
correlation with objectively quantified PA in patients with COPD
[37,38]. It has been speculated that the weak association between
self-reported activity and actual PA is due to impaired memory
[39], the possibility of misreporting activity time [40] or unnoticed
movements [37]. In addition, the effect of social desirability and
social approval on self-reports may also influence accurate recall of
the type, intensity, frequency and duration of daily PA [41].
Although there was an independent association between TEEZPAQ
and PA, patients with COPD seemed to underestimate their daily
PA level (figure 3). On the other hand, this discrepancy can also be
explained by the fact that accelerometry overestimates TEE [42].
In addition, we found that the ZPAQ cannot be used to identify
extremely inactive patients. Thus we conclude that self-reported
physical activity needs to be interpreted with care when assessing
the activity level of COPD patients.
In this study, we found significant positive correlations between the
severity of COPD (FEV1) and the average number of steps per day,
6MWD, Sit-to-Stand Test, TEEACC and TEEZPAQ. These
findings suggest that with advanced airflow limitation and disease
severity, both daily PA and physical fitness are impaired in patients
with COPD. In a recently published study by Garcia- Aymerich and
colleagues [43], physical activity of less than 60 minutes per day
Table 3. Correlations with Average Steps per Day.
Variable Coefficient r 95% CI p-Value
Performance tests
6MWD (m) 0.69 0.54–0.80 ,0.001
Sit-to-Stand Test (n) 0.51 0.31–0.66 0.001
Hand-grip strength Test (kg) 0.21 20.03–0.42 0.19
Performance-based daily
physical activity
MET (kcal/h/kg) 0.58 0.40–0.72 ,0.001
TEEACC (kcal/day) 0.46 0.25–0.63 ,0.001
TSA.3METs (min/day) 0.48 0.28–0.64 ,0.001
Questionnaire-based daily
physical activity
Stairs per week (n) 0.39 0.17–0.57 0.001
TEEZPAQ (kcal/day) 0.50 0.30–0.66 ,0.001
Correlation is expressed as Pearson’s correlation coefficient. MET: metabolic
equivalent; TEEACC: total energy expenditure per day as assessed by
accelerometry; TSA.3METs: time spend per day in activities demanding more
than 3 metabolic equivalents; TEEZPAQ: total energy expenditure per day as
assessed by the Zutphen Physical Activity Questionnaire.
doi:10.1371/journal.pone.0048081.t003
Table 4.Multiple Regression Analysis of Predictors of Physical
Activity (Steps per Day).
Model 1
Coefficient
B
Std.
Error
Coefficient
b t p-Value
Residual 22221.65 4172.01 20.53 0.596
6MWD (m) 14.67 3.40 0.57 4.32 ,0.001
PaO2 (kPa) 128.29 194.85 0.069 0.66 0.513
FEV1
(%predicted)
24.13 20.01 0.16 1.21 0.233
Age (years) 8.37 45.37 0.019 0.18 0.854
BMI (kg/m2) 237.83 62.70 20.063 20.60 0.549
Model 2
Residual 817.65 5829.85 0.14 0.889
STST (n) 155.38 73.15 0.28 2.12 0.041
PaO2 (kPa) 327.9 307.06 0.16 1.07 0.293
FEV1
(%predicted)
70.1 25.28 0.41 2.77 0.009
Age (years) 285.14 61.48 20.18 21.39 0.175
BMI (kg/m2) 26.05 83.82 0.039 0.31 0.758
Model 3
Residual 1448.95 3726.93 0.39 0.699
TEEZPAQ
(kcal/day)
1.52 0.36 0.46 4.28 ,0.001
PaO2 (kPa) 243.33 192.16 0.13 1.27 0.211
FEV1
(%predicted)
59.61 16.28 0.41 3.66 0.001
Age (years) 21.45 46.04 0.05 0.47 0.643
BMI (kg/m2) 2161.24 60.38 20.28 22.67 0.010
6MWT: 6-Minute Walk Test; STST: Sit-to-Stand Test; TEEZPAQ: total energy
expenditure per day as assessed by the Zutphen Physical Activity
Questionnaire; PaO2: partial pressure of oxygen; FEV1: forced expiratory volume
in one second; BMI: body mass index.
doi:10.1371/journal.pone.0048081.t004
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was considered a risk factor for hospital readmission in patients
with COPD. In the current study, we found that 70% of our
patients can be considered ‘‘at risk’’. Furthermore we found that
86% of our patients walked considerably less than the 10,000 steps
per day recommended for health promotion [44,45] and 82.4% of
the patients had a sedentary to extremely inactive lifestyle [15–17].
These results show that patients with COPD should be actively
encouraged to be more active and take part in physical fitness
programmes. Interestingly, compared to the PA values, the results
of the 6MWT seem to be more optimistic in absolute terms. This
discrepancy may be due to external factors, such as effort spent,
motivation and the instructions and the encouragement given to
the subjects participating in a 6MWT in contrast to their usual
activity in daily life. In addition, it may be postulated that PAL in
patients with COPD are directly linked to depressive syndromes
and anxiety [46].
The present study has certain limitations that need to be taken into
account. First, the number of subjects is quite small given the
variance in data. Second, it is difficult to identify a gold standard
measure of daily PA against which to assess the accuracy of
different methods. The methods used in this study have different
outcomes, with accuracy assessed in various ways. However, the
SenseWear ProTMarmband used in this study provides a valid and
reliable estimate of patients’ average number of steps per day [15]
and of energy expenditure [47] during slow and normal walking
speed in a laboratory setting [48].
In summary, we found that physical activity in patients with
COPD is independently associated with the 6-minute walking
distance (6MWD), the number of stands during the STST, the
total energy expenditure assessed by the self-reported physical
activity questionnaire (TEEZPAQ). These simple tests cannot be used
to identify patients with an extremely inactive lifestyle.
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